Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil for procedural sedation and analgesia in the emergency department
2013-003220-36Phase 4Terminated
- Sponsor
- Albert Schweitzer Hospital
- Start
- Jan 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil, propofol and fentanyl in acute pain (2 arms), sponsored by Albert Schweitzer Hospital. Primary endpoint: Recovery time. Started Jan 2014; status: terminated.
02
Drugs
remifentanilpropofolfentanyl
03
Conditions
acute pain
Beyond the preview
Go deeper on 2013-003220-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003220-36.